bd report revenu earn street expect revenu
updat alari pump trigger new lead lower guidanc
new guidanc top line adjust ep
exactli way new ceo tom polen want start tenur
believ leadership see bd tough patch shift
ep lead price target
result bd report cc revenu growth report
street medic revenu decreas cc report
line street estim life scienc revenu growth
cc report street estim intervent
revenu growth cc report street
estim adj gross margin increas bp yoy cc oper
margin decreas bp yoy cc adj ep
street estim
busi updat event eerili reminisc beckman coulter access issu
late fda decid accumul chang alari infus
pump market share requir new consequ bd new restrict
sell current pump must submit new data addit acceler
volume-bas tender process china trim anoth md busi
manag assum one-quart impact coronavru
item off-set strength flu test better dcb
guidanc manag lower revenu growth guidanc cc
growth report street vs previou
guidanc cc growth entir
reflect impact alari remedi loss capit sale adjust ep
guidanc lower cc growth report
street vs previou guidanc cc growth
stock confid mr polen right person
situat new guidanc appear reason assum coronaviru epidem
spread maintain ow rate price target move
reflect ep
competit new product execut foreign currenc acquisit integr
becton dickinson diversifi medic technolog compani
ep includ sbc exclud item
intra-day price
ep
debt total capit
piper sandler seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
becton dickinson compani
page
million except share per share data
updat
good sold
provis incom tax
good sold
good sold
compani report piper sandler co current disclosur inform compani locat
